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Background: Mesenchymal stem cells (MSCs) are a favored cell source for regenerative medicine because of
their multilinage potential. However, the conventional monolayer technique used to culture MSCs, inadequately
overcomes their low differentiation capacity. Culture of MSCs in multicellular spheroids, more accurately mimics the
in-vivo microenvironment; thus, resolving this problem. In this study, we assessed whether the osteoregenerative
potential of MSC spheroids is greater than that of monolayer MSCs.
Results: MSC spheroids were generated from rat MSCs (rMSCs) using low-binding plates. Real-time reverse
transcription-polymerase chain reaction and immunocytochemical analysis indicated that osteogenic properties
were accelerated in MSC spheroids compared with monolayer rMSCs when treated with an osteoblast-inducer
reagent for 7 days. Moreover, increased calcium deposition was visualized in MSC spheroids using Alizarin red
staining. In a rat calvarial defect model, micro-computed tomography and histological assays showed that MSC
spheroid-engrafted defects experienced enhanced bone regeneration.
Conclusions: Our in-vitro and in-vivo results reveal that MSCs in the spheroid culture exhibit enhanced
osteoregenerative efficiency compared with monolayer MSCs.
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Adult stem cells are widely used as a cell source for
regenerative medicine because of their multilineage po-
tential. These cells are easily harvested from bone mar-
row [1,2], adipose tissue [3,4], and other sites [5-9]. Bone
marrow contains hematopoietic stem cells, mesenchymal
stem/stromal cells (MSCs), and multipotent adult pro-
genitor cells [10-12]. MSCs are capable of self-renewal
and differentiation into several mesenchymal lineages
in-vitro and in-vivo, including bone, fat, cartilage, and
skeletal muscles [12,13]. These are considered suitable
for use in tissue regeneration. As culture in the presence
of osteogenic supplements facilitates MSCs to under-
go differentiation into the osteogenic phenotypes, MSCs
have been utilized as a cell source for osteogenic tissue
regeneration [10,11]. Bone marrow-derived MSCs have* Correspondence: johno@college.fdcnet.ac.jp
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applications.
MSCs are commonly cultured as a two-dimensional
(2D) monolayer using conventional tissue-culture tech-
niques. These 2D-monolayer techniques inadequately re-
produce the in-vivo microenvironment of stem cells,
established by extrinsic and intrinsic cellular signals and
have a profound influence on their biological functions
[14]. Culturing multipotent MSCs in a 2D adherent mo-
nolayer can alter their normal physiological behavior,
resulting in the loss of replicative ability, colony-forming
efficiency, and the differentiation capabilities over time
[15,16]. Replication of this complex in-vivo microenvir-
onment in-vitro requires highly sophisticated cell-culture
systems.
To mimic the in-vivo microenvironment more accur-
ately in-vitro, various three-dimensional (3D) culture sys-
tems have been developed. Spheroids, spherical clusters of
cells formed by self-assembly, comprise one of the best
models for the 3D culture [17,18]. Our understanding oftral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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culture of cancer cell lines. Many studies have highlighted
significant differences between 2D and 3D cultures, with
the latter better reflecting the in-vivo microenvironment
in terms of cellular heterogeneity, nutrient and oxygen
gradients, cell-cell interactions, matrix deposition, and
gene expression profiles [19-24]. Previous studies have
reported several methods of generating 3D MSC spher-
oids. Many of these methods involve the use of a cell-
suspension system or nonadherent surface to induce
the spheroid formation [25-27]. In general, these MSC
spheroids possess a greater differentiation capacity.
In this study, we examined the osteogenerative poten-
tial of the spheroids of rat MSCs (rMSCs) isolated from
bone marrow compared with monolayer rMSCs in both
in-vitro assays and a rat calvarial defect model, to elu-
cidate whether MSC spheroids exhibit enhanced bone
regeneration.
Results
Mesenchymal stem cell spheroid formation
First, we examined the generation of MSC spheroids
from rMSCs (Figure 1A) at a density of 1 × 104 cells/
well using round-bottom, low-binding plates. Culture
of rMSCs in the low-binding plates generated a single
spheroid per well. At 2 h after seeding 100 μl of rMSC
cell suspension into the plates, cells spontaneously ag-
gregated in the medium (Figure 1B). Cell aggregates
formed compact multicellular spheroids 24 h after sus-
pension culture (Figure 1C).
Furthermore, we investigated the effects of seeding
density (10,000, 1,000, or 100 per well) on the spheroid
formation. After the spheroids had been allowed to ag-
gregate for 24 h, the spheroid diameter was quantified
via bright field microscopy (n = 5 per seeding density).
The spheroid diameter increased with increasing cell
number, ranging from 83.2 ± 6 μm (6 micrometer) for the
100-cell spheroid to 530 ± 34.3 μm (34.3 micrometer) for
the 10,000-cell spheroid (Figure 2A and B). These results
indicate that the spheroid size can be controlled by cell
seeding density.Figure 1 Mesenchymal stem cell spheroid, generated from rat mesen
monolayer culture. (B) and (C) The generation of mesenchymal stem cell (
microplate culture (B). A cell aggregation formed a compact spheroid at 2Increased expression of osteogenic genes in
mesenchymal stem cell spheroids treated with an
osteoblast-inducer reagent
After treatment with an osteoblast-inducer reagent (OIR)
for 7 days, no cytological changes were observed in both
monolayer MSCs and MSC spheroids (Figure 3). The
spheroid diameter slightly decreased for 7-day treatment
with OIR, ranging from 327.8 ± 17.8 μm on day 0 to
290.3 ± 33.8 μm on day 7. To investigate whether osteo-
genic genes are induced in MSC spheroids treated with
an OIR, the relative mRNA expression levels of runt-
related transcription factor-2 (RUNX-2), osterix (OSX),
osteopontin (OPN), and bone sialoprotein (BSP) mRNA
expression were analyzed using quantitative reverse
transcription-polymerase chain reaction (RT-PCR). Com-
pared with monolayer rMSCs treated with an OIR, the
relative mRNA expression levels of OSX (normalized
to that of glyceraldehyde 3-phosphate dehydrogenase
[G3PDH] mRNA) increased by 8.27-fold (Figure 4A).
Similarly, the mRNA expression levels of RUNX-2, OPN,
and BSP increased by 1.57-, 1.94-, and 1.33-fold, re-
spectively (Figure 4B,C, and D). In contrast, alkaline
phosphatase (ALP) mRNA expression remains unchanged
in both MSC spheroids and monolayer rMSCs (Figure 4E).
The levels of expression of these osteogenic genes were
significantly upregulated in MSC spheroids compared with
monolayer rMSCs.
Immunocytochemical expression of osterix in
differentiated mesenchymal stem cell spheroids
Furthermore, we performed immunocytochemical ana-
lysis to examine the protein expression of the osteogenic
marker OSX in spheroid and monolayer rMSCs, cultured
with medium containing an OIR (Figure 5). MSC spher-
oids exhibited red-colored nuclear fluorescence (Figure 5A,
upper). In contrast, monolayer MSCs showed no staining
in the nuclei, and only faint staining was evident in the
cytoplasm (Figure 5A, lower). A significant increased
percentage of total osterix positive cells was observed
in MSC spheroids as compared to monolayer MSCs
[total: 73.0 ± 4.0 vs 18.5 ± 1.8 (p < 0.01)] (Figure 5B).chymal stem cell lines. (A) Parental cell line grown permanently as a
MSC) spheroids. Cellular aggregation of MSCs was observed 2 h after a
4 h (C). Scale bars = 100 μm (a and c) and 1 mm (B).
Figure 2 Effect of seeding densities on a spheroid formation. (A) Representative images of mesenchymal stem cell (MSC) spheroids grown
on low-binding plates at 24 h after implantation. Scale bar = 100 μm. (B) The diameter of MSC spheroids increased linearly with increasing
cell number.
Figure 3 Cytological images of differentiated monolayer mesenchymal stem cells (MSC) and MSC spheroids. No cytological changes
were observed inboth monolayer MSCs and MSC spheroids cultured with an osteoblast-induced reagent. Untreated monolater MSCs (A), treated
monolayer MSCs (B), untreated MSC spheroids (C), and treated MSC spheroids (D). Bars = 100 μm.
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Figure 4 Expression of osteogenic marker genes in both mesenchymal stem cell spheroids and monolayer rat mesenchymal stem
cells. Quantitative reverse transcription-polymerase chain reaction results for runt-related transcription factor-2, osterix, osteopontin, and bone
sialoprotein, and alkaline phosphatase mRNA expression in mesenchymal stem cell (MSC) spheroids (black column) and monolayer rat MSCs
(rMSCs; gray column) treated with an osteoblast-inducer reagent (OIR). Results are expressed as fold-increases in mRNA expression (normalized to
that of glyceraldehyde 3-phosphate dehydrogenase mRNA) and compared with results for monolayer rMSCs treated with an OIR on Day 7. mRNA
expression levels of osteogenic genes, other than alkaline phosphatase (ALP) (E), in MSC spheroids were increased, compared with those of
monolayer MSCs (A-D). Vertical lines represent the mean ± standard deviation of three independent experiments, each performed in triplicate.
*Significantly different at p < 0.05 compared with monolayer rMSCs. OSX, osterix; RUNX-2, runt-related transcription factor-2; OPN, osteopontin;
BSP, bone sialoprotein; ALP, alkaline phosphatase.
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the nuclei of spheroid MSCs treated with an OIR for
7 days.Increased alkaline phosphatase staining and induction of
calcified deposits in mesenchymal stem cell spheroids
treated with an osteoblast-inducer reagent
ALP staining intensity and Alizarin red (AR) deposits
are well-defined cytochemical markers of osteogenesis
and are considered to reflect the differentiation into os-
teoblasts [28,29]. We compared the staining intensity
for ALP and AR in MSC spheroids and monolayer rMSCs,
cultured with an OIR for 7 days. ALP staining intensity
was evident in both MSC spheroids (Figure 6A) and mo-
nolayer rMSCs (Figure 6B) cultured with an OIR for 7
days. These results indicate that both spheroids and mo-
nolayer cells can differentiate into progenitors for bone
formation after an OIR stimulation.
AR staining of calcified deposits was used to examine
the mineralization of the extracellular matrix. We in-
vestigated whether MSC spheroids cultured with an
OIR for 7 days, exhibit a late period of matrix matur-
ation. The centeral areas of MSC spheroids (Figure 7A)
appeared red, whereas no spots of AR staining were
evident in monolayer rMSCs (Figure 7B). These results
indicate that MSC spheroids treated with an OIR in-
duce more calcification than monolayer rMSCs.Mesenchymal stem cell spheroids enhance the healing of
rat calvarial defects
To determine whether MSC spheroids enhance bone
regeneration, we implanted MSC spheroids/Matrigel™
(BD Biosciences, San Jose, CA, USA), monolayer rMSCs/
Matrigel™, Matrigel™ alone, or nothing (blank) into rat cal-
varial bone defects. The area of regenerated bone was in-
vestigated by micro-computed tomography (micro-CT)
scanning (Figure 8A). At 2 and 4 weeks after implant-
ation, bone defect areas were still evident in the blank,
Matrigel™ alone, and monolayer rMSC/Matrigel™ groups.
Conversely, the defect areas were small in the MSC sphe-
roid/Matrigel™ group because they were filled with rege-
nerated bones.
We quantified these micro-CT findings to yield the
percentage of defect healing by quantifying the pixels in
these defects. These results are summarized in Figure 7B.
MSC spheroid/ Matrigel™ -implanted rats (49.4 ± 8.7%
at 2 weeks; 72.2 ± 7.0% at 4 weeks) showed higher per-
centages of new bones at 4 weeks compared with rats
in the other groups. The area of regenerated bones in
rats in the other three groups was less than 55% (blank:
25.6 ± 4.9% and 45.0% ± 8.1%, Matrigel™ alone: 26.3 ± 5.0%
and 46.2 ± 5.6%, monolayer rMSC/ Matrigel™: 39.9 ± 6.0%
and 52.3 ± 10.2% at 2 and 4 weeks, respectively]. Thus, the
MSC spheroids group showed higher bone regeneration
in the peripheral area surrounding the defect compared
with other groups.
Figure 5 Immunocytochemical analysis of osterix expression in mesenchymal stem cell spheroids treated with an osteoblast-inducer
reagent for 7 days. (A) Compared with monolayer mesenchymal stem cell (MSC; lower), positive cells (red) with anti- osterix antibody were
increased in MSC spheroids (upper). 4′,6-diamidino-2-phenylindole (DAPI) was used to label nuclei (blue). Arrows, positive reaction in nuclei. Scale
bars = 100 μm. (B) Significantly increased percentage of osterix positive cells was observed in MSC spheroids when compared to monolayer MSCs
(*, p < 0.01).
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well generated in the MSC spheroids group compared
with the other groups. At 4 weeks after implantation,
the bone defects were almost replaced by regenerated
bone in the MSC spheroids group. In the other groups,
some newly regenerated bones were evident, but con-
siderable areas of the bone defects remained filled withFigure 6 Alkaline phosphatase staining in mesenchymal stem cell sph
phosphatase staining was observed in both mesenchymal stem cell (MSC)fibrous connective tissue. No inflammatory changes were
observed in any group (left and middle columns in
Figure 9A). Azan Mallory staining showed that areas of
the bone defects were filled with mature collagenous
fibers in the blank, Matrigel™ alone, monolayer MSC/
Matrigel™ groups (right column in Figure 9A). A histo-
morphometric analysis represented that 74.4 ± 1.9% anderoids and monolayer rat mesenchymal stem cells. Alkaline
spheroids (A) and monolayer rat MSCs (B). Scale bar = 100 μm.
Figure 7 Mineralization of mesenchymal stem cell spheroids cultured with an osteoblast-inducer reagent. Mesenchymal stem cell (MSC)
spheroids (A) and monolayer rat MSCs (B) were incubated for 7 days with an osteoblast-inducer reagent (OIR). Matrix mineralization was
visualized in OIR-cultured MSC spheroids using Alizarin red staining. Scale bar = 100 μm.
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bone in the blank and Matrigel™ alone groups, respect-
ively. In the monolayer MSC/Matrigel™ group, 73.9 ± 1.8%
of the defects were filled with newly regenerated bone
(Figure 9B).
Discussion
The spheroid culture system has some advantages over
the standard monolayer culture. The methods of the
spheroid culture, allows the cells to adapt to their native
morphology, facilitating greater cell-cell contacts and in-
teractions between the cells and the extracellular matrix.
In this study, we present two lines of evidence to support
the concept that MSC spheroids exhibit enhanced os-
teogenic potential compared with monolayer rMSCs cul-
tured, using conventional techniques. First, in-vitro assaysFigure 8 Healing of rat calvarial defects assessed by micro-computed
the calvaria, 0, 2, and 4 weeks after implantation of the indicated materials.
mesenchymal stem cells (MSCs)/ Matrigel™, and MSC spheroids/ Matrigel™
unfilled. (B) Quantitative results for micro-CT analysis. Healing of defects wa
area as quantified by micro-CT analysis (n = 5 per group). There were statis
spheroids group and that in the other groups (p < 0.05). There are no signiconfirmed that MSC spheroids upregulate osteogenic
genes and proteins and also exhibit increased calcium
deposition. Second, the implantation of MSC spheroids
in vivo enhanced bone regeneration in rat calvarial
defects.
A standardized microplate method used in this study
generated a single MSC spheroid in each well. The round-
bottom, low-binding plates had the following desirable
characteristics: (i) a single spheroid per well, centered for
ease of optical imaging; (ii) high reproducibility; (iii) sim-
ple harvesting for further analysis [30]. It was possible to
form spheroids by altering the initial seeding density of
rMSCs. Spheroids size must be important because of limi-
tations in the length of nutrient transport by diffusion.
Curcio et al. reported that the spheroid radii greater than
200 μm rendered cells in their core vulnerable to hypoxiatomography. (A) Micro-computed tomography (micro-CT) images of
Newly regenerated bone in the blank, Matrigel™ alone, monolayer rat
groups were evaluated. In the blank group, the defect was left
s shown as the fraction of new bone with respect to the total defect
tical differences between the area of new bone formed in the MSC
ficant difference in groups of gray columns jointed to horizontal bar.
Figure 9 Histological analysis of regenerated bone after implantation. (A) Hematoxylin and eosin (HE) and Azan Mallory staining of calvarial
tissue sections was conducted 4 weeks after implantation. Newly regenerated bone in the blank, Matrigel™ alone, monolayer rat mesenchymal
stem cells (MSCs)/Matrigel™, and MSC spheroids/Matrigel™ groups were evaluated histologically. The left and middle columns showed HE
staining at low and high magnification, respectively. Solid lines indicate the edges of the host bone. Dotted lines indicate the defect filled with
the connective tissue. In MSC spheroids/Matrigel™ group, the defect were filled with newly regenerated bone. In the right column showing Azan
Mallory staining, the defects of the blank, Matrigel™ alone, monolayer rat mesenchymal stem cells (MSCs)/Matrigel™ groups were filled with
mature collagenous fibers. Scale bar in the left column = 1 mm. Scale bars in the middle and right columns = 100 μm. (B) Percentages of newly
regenerated bone in relation to the size of the original defect evaluated histomorphometricly 4 weeks after implantation. Replacement of newly
bone in MSC spheroids/ Matrigel™ group was greater than that in other groups. *, significantly different at p < 0.05 compared with other groups.
There are no significant difference in groups of gray columns jointed to horizontal bar.
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ments, we used the spheroids containing approximately
10,000 cells with a mean radius of approximately 200 μm.
Conversely, delivery of a substantial number of cells is re-
quired for cell-based therapies to drive tissue formation,
and larger spheroids facilitate the transplantation of fewer
aggregates.
The results of our in-vitro assays indicate that os-
teogenic properties are accelerated in MSC spheroids
treated with an OIR. We compared changes the osteo-
genic gene expression profiles of 3D MSC spheroids vs.
2D monolayer rMSCs by quantitative RT-PCR. Expres-
sion of the RUNX-2, OSX, OPN, and BSP genes were
upregulated in MSC spheroids treated with an OIR com-
pared with monolayer rMSCs. The process of osteo-
blastic differentiation is regulated by multiple factors
and signaling pathways. Among the upregulated genes,
RUNX-2, also called core-binding factor A1, and OSX
are often referred to as the “master switch” of osteo-
genic differentiation [32,33]. It is established that bone
genes are crucial for the generation of a mineralized tis-
sue, and are usually analyzed during the early phases of
osteogenic differentiation. MSC spheroids treated with
an OIR for 7 days appear to begin toward the osteo-
genic differentiation. Our immunocytochemical findings
showing OSX expression in MSC spheroids support this
speculation.
Interestingly, our PCR results also showed an upregu-
lation of the intermediate to late markers of osteoge-
nesis, OPN and BSP. OPN is a noncollagenous, secretedglycosylation phosphoprotein expressed during both the
early and the intermediate stages of osteogenesis [34-36].
BSP is also a noncollagenous, acidic phosphoprotein nor-
mally expressed in mineralized tissues such as bone and
dentin [37]. Upregulation of these genes prompts us to
suggest that they may serve as a matrix-associated signal
directly promoting osteogenic differentiation and resulting
in the increased production of a mineralized matrix in
MSC spheroids. Using AR staining, we found increased
calcium deposition in MSC spheroids treated with an OIR
for 7 days. It is difficult to explain why the mixtures of
various differentiation phases are contained within MSC
spheroids. We believe that the multicellular spheroids
consist of cells at various stages of osteogenic differenti-
ation. Future work will address how osteogenic differenti-
ation is regulated in the cells consisting of MSC spheroids.
In our in-vitro experiments, there were no differences
in ALP gene expression and ALP activity between MSC
spheroids and monolayer rMSCs. ALP is another im-
portant marker, as an effector protein responsible for
osteoprogenitor markers and mineralization of the extra-
cellular matrix during osteogenic differentiation [38]. In
this study, we found that the expression levels of ALP
mRNA in monolayer rMSCs treated with an OIR for
7 days was identical to that in MSC spheroids. ALP
staining was of identical intensity between monolayer
rMSCs and MSC spheroids treated with an OIR for 7
days, but no AR deposits were observed in monolayer
rMSCs. These results suggest that monolayer rMSCs can
differentiate into a progenitor phase without the initiation
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with an OIR exhibit enhanced the differentiation capabilil-
ties compared with monolayer rMSCs.
Micro-CT analysis of MSC spheroid-engrafted calvarial
defects in rats indicates that these spheroids have a dra-
matic effect on bone regeneration. Histological findings
complemented these micro-CT results, which showed
that a bone bridge had almost covered the defect in rats
in the MSC spheroids group, although the fibrous con-
nective tissue remained in the defect in rats in the other
groups. Based on the histological findings of engrafted
defects in the control groups, we suggest that the bone
healing process consistes of the extensions of new bone
from the edges of the defect. This healing process is
supported by our previous report [29]. Our in-vitro and
in-vivo results reveal that MSCs in the spheroid culture
exhibit enhanced osteogenic efficiency compared with
those in the monolayer culture. However, the detailed
mechanisms that enhanced in-vitro osteogenesis and
in-vivo bone regeneration by which MSC spheroids occur
remain unclear. Future studies will address the detailed
effects of MSC spheroids on microenvironments during
the induction of osteogeneis in bone defects.Conclusion
Our in-vitro experiments on osteogenic induction showed
that MSC spheroids possessed enhanced osteogenic po-
tential compared with monolayer rMSCs. Moreover, we
demonstrated that engrafted MSC spheroids induced effi-
cient bone regeneration in calvarial defects in rats. Based
on these results, we conclude that MSCs in the spheroid
culture exhibit enhanced the osteogenic capabilities.Methods
Cell lines
Bone marrow-derived rMSCs, isolated from Fischer 344
rats, were purchased from Lonza Group AG (Basel,
Switzerland) and expanded according to the established
protocols. Briefly, cryopreserved rMSCs were thawed
and plated onto a 10-cm tissue-culture dish in 10 ml
Dulbecco’s modified Eagle’s medium (DMEM; Wako
Pure Chemical Industiries,Ltd., Osaka, Japan) supplemen-
ted with 10% fetal bovine serum (FBS; Sigma-Aldrich
Corporation, St. Louis, MO, USA), and 1% (v/v) penicillin/
streptomycin (PS; Invitrogen/GIBCO, Carlsbad, CA, USA)
for 7 days at 37°C in a humidified 5% CO2 atmosphere.
The medium was changed every 3 days. After allowing the
adherent cells to grow to approximately 80% confluence,
they were detached from the tissue culture plate using
0.25% trypsin- 1 mM ethylenediamine tetraacetic acid
(EDTA) solution (Sigma-Aldrich Corporation), counted,
and either replated for monolayer cultures or used for
spheroid formation.Mesenchymal stem cell spheroid formation
Dissociated rMSC monolayers (Passage 3) were resus-
pended in medium to obtain a single cell suspension.
MSCs (8 × 105 cells/ml, corresponding to approximately
100, 1,000, and 10,000 cells/well) were added to Nunc®Low
Cell Binding Surface 96-well plates (Thermo Scientific
Nunc A/S, Roskilde, Denmark) and incubated in DMEM
medium supplemented with FBS and PS at 37°C for up to
7 days.
Osteogenic induction in mesenchymal stem cell spheroids
To generate osteogenic differentiation, MSC spheroids
were cultured with DMEM in the presence of OIR (Takara
Bio Inc., Otsu, Japan), which included ascorbic acid, hy-
drocortisone, and β-glycerophosphate. Culture of MSC
spheroid was allowed to grow for 7 days with media ex-
changed every 2 days. For immunocytochemistry and,
ALP and AR staining, MSC spheroids incubated with
OIR were removed from the well and plated onto 13-mm
cover glass for 2 hours. Parental rMSCs were seeded on to
13-mm cover glasses and cultured with DMEM contai-
ning 10% (v/v) FBS and an OIR for 7 days.
Real-time reverse transcription-polymerase chain reaction
The total RNA was isolated from differentiated spheroids
or monolayer MSCs cultured with the OIR for 7 days
using a High Pure RNA Isolation Kit (Roche Diagnostics,
Basel, Switzerland), according to the manufacturer’s in-
structions. Total RNA (1 μg) was transcribed into cDNA
using random, oligo (dT) primers, and reverse transcript-
ase in a total volume of 10 μl (ReverTra Ace® qPCR RT
Kit; Toyobo Co., Ltd., Osaka, Japan). Reverse transcription
was performed at 37°C for 15 min, at 50°C for 5 min,
and then at 98°C for 5 min. The resulting templates
were amplified in a LightCycler® Nano RT-PCR system
(Roche Diagnostics) according to the manufacturer’s pro-
tocol. G3PDH was used as an internal control. Relative
mRNA expression was determined as the ratio of RUNX-2,
OSX, OPN, or BSP mRNA to G3PDH mRNA. The se-
quence of the specific primers and Universal ProbeLibrary
(Roche Diagnostics) probe numbers used for the quantita-
tive RT-PCR analysis are listed in Table 1. All reactions
were run in triplicate. Results are expressed as fold-
increases in mRNA expression (normalized to that of
G3PDH mRNA) and compared with results for mono-
layer rMSCs treated with an OIR on Day 7.
Immunocytochemical detection of osterix in
mesenchymal stem cell spheroids
After culturing for the indicated time, spheroids and
parental cells on 13-mm cover glass were fixed with 4%
paraformaldehyde for 10 min and then washed in 0.1%
Triton X-100 in phosphate-buffered saline (PBS) for
15 min. They were incubated with a rabbit polyclonal
Table 1 Primers and probes used in this study













G3PDH, glyceraldehyde 3-phosphate dehydrogenase; RUNX-2, runt-related
transcription factor-2; OSX, osterix; OPN, osteopontin; BSP, bone sialoprotein;
ALP, alkaline phosphatase.
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at 4°C overnight. After washing with PBS, both spheroids
and cells were incubated in a mixture of anti-rabbit
Immunoglobulin G antibody conjugated with Alexa Fluor®
568 (1:200; Molecular Probes, Eugene, OR, USA). To
visualize the nuclei, immunostained spheroids and cells
were counterstained with 4, 6-diamidino-2-phenylindole
(DAPI; Vector Laboratories, Inc., Burlingame, CA, USA).
Alkaline phosphatase and Alizarin red staining
ALP and AR staining were assessed in both MSC spher-
oids and monolayer rMSCs induced after exposure to the
OIR for 7 days. ALP staining was performed using an ALP
staining kit (Takara Bio Inc., Otsu, Japan), according to
the manufacturer’s instructions. Calcified deposits were
detected by AR staining. Both MSC spheroids and mono-
layer rMSCs were fixed for 10 min in 4% paraformalde-
hyde in PBS and was rinsed twice with distilled water. The
cells were stained at room temperature for 5 min with AR.
The rat calvarial bone defect model
Ten-week-old male Fischer rats (weight approximately
250 g; n = 20) were anesthetized with 2% isoflurane
(Abbott Laboratories, Abbott Park, IL, USA) and an air
mixture gas flow of 1 l/min using an anesthesia gas ma-
chine (Anesthesia Machine SF-B01; MR Technology,
Inc., Tsukuba, Japan). After shaving the skin, an incision
was made in the skull, and the periosteum was opened,
exposing the surface of the calvarial bones. A circular
bone defect (full-thickness, 5 mm diameter) was cre-
ated in the left parietal bone with a trephine drill and
was irrigated with saline to remove bone debris. MSC
spheroids were then implanted into the defects. Five
MSC spheroids or monolayer rMSCs (5 × 104 cells), whichhad been cultured in medium containing the OIR for
7 days, were loaded into 20 μl Matrigel™ on ice and trans-
planted into the defects at room temperature. Controls for
the transplant experiments included calvarial defects im-
planted with or without Matrigel™. Our animal experi-
mentation protocols were approved by the Animal Care
and Use Committee of Fukuoka Dental College, Fukuoka,
Japan (No. 13006).
Evaluation of bone regeneration
Bone regeneration was evaluated using an in-vivo micro-
CT system (Skyscan-1176 Micro-CT Scanner; Burker
MicroCT, Kontich, Belgium) at 50 kVp and 500 μA on
rats under anesthesia (as described above), 4 weeks after
implantation. Each image data set consisted of a scan
size of approximately 35 mm. The percentage of newly
formed bone in each calvarial bone defect was calculated
as previously described [28,29].
After micro-CT scanning, rats were sacrificed by in-
jecting an overdose of isoflurane. Subsequently, the cra-
nial tissues containing MSC spheroids, monolayer rMSCs,
or control substances were immediately excised. Tissue
specimens were fixed in 4% paraformaldehyde in PBS,
decalcified in 10% EDTA for 4 weeks at 4°C, and then
was embedded in paraffin. Paraffin sections were then
stained with hematoxylin and eosin and Azan Mallory
to visualize any histological changes. In histomorpho-
metric analysis, the percentage of the volume of the
newly formed bone per the original volume of the de-
fect was calculated.
Statistical analysis
The results are presented as means ± standard deviation.
Group results were compared using one-way analysis
of variance and Scheffe’s multiple comparison tests. A
p-value of <0.05 was considered statistically significant.
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